Evidence map›Paper›PMID 21224736›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2011

Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi.

Maureen Braun, Mark M Kabue, Eric D McCollum, Saeed Ahmed, Maria Kim, Leela Aertker, Marko Chirwa, Michael Eliya, Innocent Mofolo, Irving Hoffman and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02682810 (Z 1303 - Point-of-Care Virologic Testing to Improve Outcomes of HIV-Infected Children), which is not on this map. Cited by 67 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02682810 nacompletednot on this mapstarted 2016, after this paper: background citation

Z 1303 - Point-of-Care Virologic Testing to Improve Outcomes of HIV-Infected Children

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2016 to 2019Enrolled4,000ConditionsEarly Infant HIV DiagnosisArmsDNA PCR HIV diagnostic test, Alere Q
3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Maureen BraunUniversity of North Carolina Project, Lilongwe, Malawi.
Mark M Kabue
Eric D McCollum
Saeed Ahmed
Maria Kim
Leela Aertker
Marko Chirwa
Michael Eliya
Innocent Mofolo
Irving Hoffman
Peter N Kazembe
Charles van der Horst
Mark W Kline
Mina C Hosseinipour

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
UNC CENTER FOR HEALTH PROMOTION AND DISEASE PREVENTIONU48DP001944 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AMMERMAN, ALICE S · 2009 to 2013
$15.1M
AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW001039 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ADIMORA, ADAORA A · 1998 to 2013
$9.9M
BAYLOR INTERNATIONAL PEDIATRIC AIDS INITIATIVED43TW001036 · FIC · BAYLOR COLLEGE OF MEDICINE · PI KLINE, MARK W. · 2000 to 2015
$7.6M
Multidisciplinary Training Program in Pediatric PulmonaryT32HL072748 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Joseph Michael Collaco · 2003 to 2026
$6.1M
ACL HHS U48DP001944FIC NIH HHS D43 TW001036FIC NIH HHS D43 TW001039FIC NIH HHS D43 TW01036FIC NIH HHS R24 TW007988NCCDPHP CDC HHS 1U48DP001944NCCDPHP CDC HHS U48 DP001944NHLBI NIH HHS T32 HL072748NIAID NIH HHS P30 AI050410NIAID NIH HHS #P30 AI50410
6 · The paper itself

Abstract

objectiveTo assess the continuity of care and outcome of pediatric HIV prevention, testing, and treatment services, focusing on early infant diagnosis with DNA polymerase chain reaction (PCR).

designA retrospective observational cohort.

methodsMaternal HIV antibody, infant HIV DNA PCR test results, and outcome data from HIV-infected infants from the prevention of mother-to-child transmission, early infant diagnosis, and pediatric HIV treatment programs operating in Lilongwe, Malawi, between 2004 and 2008 were collected, merged, and analyzed.

resultsOf the 14,669 pregnant women who tested HIV antibody positive, 7875 infants (53.7%) received HIV DNA PCR testing. One thousand eighty-four infants (13.8%) were HIV infected. Three hundred twenty (29.5%) children enrolled into pediatric HIV care, with 202 (63.1%) at the Baylor Center of Excellence. Among these, antiretroviral therapy was initiated on 110 infants (54.5%) whose median age was 9.1 months (interquartile range, 5.4-13.8) and a median of 2.5 months (interquartile range, 1.4-5.2) after HIV clinic registration. Sixty-nine HIV-infected infants (34.2%) died or were lost by December 2008. Initiation of antiretroviral therapy increased the likelihood of survival 7-fold (odds ratio, 7.1; 95% confidence interval, 3.68 to 13.70).

conclusionsSeparate programs for maternal and infant HIV prevention and care services demonstrated high attrition rates of HIV-exposed and HIV-infected infants, elevated levels of mother-to-child transmission, late infant diagnosis, delayed pediatric antiretroviral therapy initiation, and high HIV-infected infant mortality. Antiretroviral therapy increased HIV-infected infant survival, emphasizing the urgent need for improved service coordination and strategies that increase access to infant HIV diagnosis, improve patient retention, and reduce antiretroviral therapy initiation delays.

Indexed as

Child Health ServicesMaternal Health ServicesAIDS SerodiagnosisAntiretroviral Therapy, Highly ActiveCohort StudiesDelivery of Health Care, IntegratedEarly DiagnosisFemaleHealth Planning GuidelinesHIV-1HIV AntibodiesHIV InfectionsHumansInfantInfant MortalityInfectious Disease Transmission, VerticalHIV Antibodies

Identifiers

PMID21224736
PMCPMC3112277

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.